Top News:
Medical - Feb 14, 2017
Allergan Plc, a United States-based Botox maker, agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc., the manufacturer of a fat-reducing treatment.
Company - Jan 31, 2017
Mylan said in a statement that the Federal Trade Commission (FTC) confirmed several months ago for information about EpiPen, as part of a preliminary investigation.